Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery.
Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery.
复制标题
DOI:
10.3390/ijms23063041
复制
发表时间:
2022-03-11
影响因子:
5.6
通讯作者:
Hallahan DE
中科院分区:
文献类型:
--
作者:
Kapoor V;Singh AK;Lewis CD;Deore S;Hallahan DE
Therapeutic antibodies used to treat cancer are effective in patients with advanced-stage disease. For example, antibodies that activate T-lymphocytes improve survival in many cancer subtypes. In addition, antibody–drug conjugates effectively target cytotoxic agents that are specific to cancer. This review discusses radiation-inducible antigens, which are stress-regulated proteins that are over-expressed in cancer. These inducible cell surface proteins become accessible to antibody binding during the cellular response to genotoxic stress. The lead antigens are induced in all histologic subtypes and nearly all advanced-stage cancers, but show little to no expression in normal tissues. Inducible antigens are exploited by using therapeutic antibodies that bind specifically to these stress-regulated proteins. Antibodies that bind to the inducible antigens GRP78 and TIP1 enhance the efficacy of radiotherapy in preclinical cancer models. The conjugation of cytotoxic drugs to the antibodies further improves cancer response. This review focuses on the use of radiotherapy to control the cancer-specific binding of therapeutic antibodies and antibody–drug conjugates.
登录
查看更多内容
影响因子:
11.2
作者:
Green DJ;Frayo SL;Lin Y;Hamlin DK;Fisher DR;Frost SH;Kenoyer AL;Hylarides MD;Gopal AK;Gooley TA;Orozco JJ;Till BG;O'Steen S;Orcutt KD;Wilbur DS;Wittrup KD;Press OW
通讯作者:
Press OW
影响因子:
15.9
作者:
Gul, Nuray;Babes, Liane;van Egmond, Marjolein
通讯作者:
van Egmond, Marjolein
影响因子:
50.3
作者:
Hallahan, D;Geng, L;Clanton, J
通讯作者:
Clanton, J
影响因子:
5.6
作者:
Gogesch P;Dudek S;van Zandbergen G;Waibler Z;Anzaghe M
通讯作者:
Anzaghe M
影响因子:
--
作者:
Dadey DY;Kapoor V;Khudanyan A;Urano F;Kim AH;Thotala D;Hallahan DE
通讯作者:
Hallahan DE